These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1062 related articles for article (PubMed ID: 19837821)

  • 1. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
    Badesch DB; Raskob GE; Elliott CG; Krichman AM; Farber HW; Frost AE; Barst RJ; Benza RL; Liou TG; Turner M; Giles S; Feldkircher K; Miller DP; McGoon MD
    Chest; 2010 Feb; 137(2):376-87. PubMed ID: 19837821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
    Frost AE; Farber HW; Barst RJ; Miller DP; Elliott CG; McGoon MD
    Chest; 2013 Jan; 143(1):185-195. PubMed ID: 22661451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
    Frost AE; Badesch DB; Barst RJ; Benza RL; Elliott CG; Farber HW; Krichman A; Liou TG; Raskob GE; Wason P; Feldkircher K; Turner M; McGoon MD
    Chest; 2011 Jan; 139(1):128-37. PubMed ID: 20558556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the Need for Upfront Combination Therapy in Pulmonary Arterial Hypertension.
    Bajwa AA; Qureshi T; Shujaat A; Seeram V; Jones LM; Al-Saffar F; Cury JD
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):395-400. PubMed ID: 25613465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension.
    Oliveira RK; Ferreira EV; Ramos RP; Messina CM; Kapins CE; Silva CM; Ota-Arakaki JS
    J Heart Lung Transplant; 2014 Feb; 33(2):157-62. PubMed ID: 24268673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of pulmonary hemodynamic parameters in cardiac transplant candidates.
    Sobieszczańska-Małek M; Zieliński T; Piotrowski W; Korewicki J; Of Polkard-Hf OB
    Cardiol J; 2014; 21(5):532-8. PubMed ID: 24526510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
    Distler O; Bonderman D; Coghlan JG; Denton CP; Grünig E; Khanna D; McLaughlin VV; Müller-Ladner U; Pope JE; Vonk MC; Di Scala L; Lemarie JC; Perchenet L; Hachulla É
    Arthritis Rheumatol; 2024 May; 76(5):777-782. PubMed ID: 38146100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pulmonary Capillary Wedge Pressure on Long-Term Mortality in Patients With Pulmonary Arterial Hypertension Treated With Parenteral Trepostinil.
    Patel JK; Rao Y; Strachan P
    Heart Lung Circ; 2018 Feb; 27(2):183-189. PubMed ID: 28400191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.
    Brown LM; Chen H; Halpern S; Taichman D; McGoon MD; Farber HW; Frost AE; Liou TG; Turner M; Feldkircher K; Miller DP; Elliott CG
    Chest; 2011 Jul; 140(1):19-26. PubMed ID: 21393391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
    van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
    Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
    Bergot E; Sitbon O; Cottin V; Prévot G; Canuet M; Bourdin A; de Groote P; Rottat L; Gressin V; Jaïs X; Humbert M; Simonneau G
    Int J Cardiol; 2014 Apr; 172(3):561-7. PubMed ID: 24529947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic Thresholds for Precapillary Pulmonary Hypertension.
    Gerges C; Gerges M; Skoro-Sajer N; Zhou Y; Zhang L; Sadushi-Kolici R; Jakowitsch J; Lang MB; Lang IM
    Chest; 2016 Apr; 149(4):1061-73. PubMed ID: 26501411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry.
    Humpl T; Berger RMF; Austin ED; Fasnacht Boillat MS; Bonnet D; Ivy DD; Zuk M; Beghetti M; Schulze-Neick I
    Cardiol Young; 2017 Aug; 27(6):1123-1132. PubMed ID: 27995825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics.
    Badlam JB; Badesch DB; Austin ED; Benza RL; Chung WK; Farber HW; Feldkircher K; Frost AE; Poms AD; Lutz KA; Pauciulo MW; Yu C; Nichols WC; Elliott CG;
    Chest; 2021 Jan; 159(1):311-327. PubMed ID: 32858008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension.
    Klinger JR; Oudiz RJ; Spence R; Despain D; Dufton C
    Am J Cardiol; 2011 Jul; 108(2):302-7. PubMed ID: 21545989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition, epidemiology and registries of pulmonary hypertension.
    Awdish R; Cajigas H
    Heart Fail Rev; 2016 May; 21(3):223-8. PubMed ID: 26438630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure.
    Halpern SD; Taichman DB
    Chest; 2009 Jul; 136(1):37-43. PubMed ID: 19255293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.